Extended Data Fig. 2: Validation of sBLISS for the detection of colibactin-associated DSB break points. | Nature Medicine

Extended Data Fig. 2: Validation of sBLISS for the detection of colibactin-associated DSB break points.

From: Colibactin DNA-damage signature indicates mutational impact in colorectal cancer

Extended Data Fig. 2

a, In contrast to infection with pks- E. coli, Caco-2 cells infected with colibactin-producing pks+ E. coli displayed γH2AX expression, megalocytosis and multinucleation. Representative image of two independent experiments. b, sBLISS signal of etoposide-induced DSBs showed increased counts at TSS as compared to untreated control conditions. c, This heatmap indicates the log2 odds ratio of break enrichment in genomic region collections (FDR < 5%) as compared to the rest of the genome: untreated, etoposide-treated, pks+ E. coli-infected and pks- E. coli-infected Caco-2 cells. Rows represent known genomic regions from different genome annotation collections. Etoposide treatment increased DSB enrichment in TSS-associated features, while DSBs in pks+ E. coli-infected cells show a rather weaker enrichment compared to untreated and pks- E. coli-infected cells, indicating a more uniform distribution across the genome.

Back to article page